These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 9196277)
21. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2. García Pastor P; De Rosa S; De Giulio A; Payá M; Alcaraz MJ Br J Pharmacol; 1999 Jan; 126(1):301-11. PubMed ID: 10051149 [TBL] [Abstract][Full Text] [Related]
22. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Stephenson D; Rash K; Smalstig B; Roberts E; Johnstone E; Sharp J; Panetta J; Little S; Kramer R; Clemens J Glia; 1999 Aug; 27(2):110-28. PubMed ID: 10417811 [TBL] [Abstract][Full Text] [Related]
23. Localization of cytosolic phospholipase A2 messenger RNA mainly in neurons in the rat brain. Kishimoto K; Matsumura K; Kataoka Y; Morii H; Watanabe Y Neuroscience; 1999; 92(3):1061-77. PubMed ID: 10426546 [TBL] [Abstract][Full Text] [Related]
24. PX-52, A novel inhibitor of 14 kDa secretory and 85 kDa cytosolic phospholipases A2. Franson RC; Rosenthal MD Adv Exp Med Biol; 1997; 400A():365-73. PubMed ID: 9547578 [TBL] [Abstract][Full Text] [Related]
25. Phosphorylation and calcium influx are not sufficient for the activation of cytosolic phospholipase A2 in U937 cells: requirement for a Gi alpha-type G-protein. Burke JR; Davern LB; Gregor KR; Todderud G; Alford JG; Tramposch KM Biochim Biophys Acta; 1997 Sep; 1341(2):223-37. PubMed ID: 9357962 [TBL] [Abstract][Full Text] [Related]
26. Beta 1 integrin cross-linking inhibits CD16-induced phospholipase D and secretory phospholipase A2 activity and granule exocytosis in human NK cells: role of phospholipase D in CD16-triggered degranulation. Milella M; Gismondi A; Roncaioli P; Palmieri G; Morrone S; Piccoli M; Frati L; Cifone MG; Santoni A J Immunol; 1999 Feb; 162(4):2064-72. PubMed ID: 9973479 [TBL] [Abstract][Full Text] [Related]
27. Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. Wu YL; Jiang XR; Newland AC; Kelsey SM J Immunol; 1998 Jun; 160(12):5929-35. PubMed ID: 9637506 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Nakamura H; Hirabayashi T; Someya A; Shimizu M; Murayama T Eur J Pharmacol; 2004 Jan; 484(1):9-17. PubMed ID: 14729377 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of allergic and non-allergic inflammation by phospholipase A2 inhibitors. Tibes U; Vondran A; Rodewald E; Friebe WG; Schäfer W; Scheuer W Int Arch Allergy Immunol; 1995; 107(1-3):432-4. PubMed ID: 7613203 [No Abstract] [Full Text] [Related]
30. Immunochemical detection of arachidonoyl-preferential phospholipase A2. Fujimori Y; Murakami M; Kim DK; Hara S; Takayama K; Kudo I; Inoue K J Biochem; 1992 Jan; 111(1):54-60. PubMed ID: 1607364 [TBL] [Abstract][Full Text] [Related]
31. CaM kinase IIalpha mediates norepinephrine-induced translocation of cytosolic phospholipase A2 to the nuclear envelope. Fatima S; Yaghini FA; Ahmed A; Khandekar Z; Malik KU J Cell Sci; 2003 Jan; 116(Pt 2):353-65. PubMed ID: 12482921 [TBL] [Abstract][Full Text] [Related]
32. Properties and purification of an arachidonoyl-hydrolyzing phospholipase A2 from a macrophage cell line, RAW 264.7. Leslie CC; Voelker DR; Channon JY; Wall MM; Zelarney PT Biochim Biophys Acta; 1988 Dec; 963(3):476-92. PubMed ID: 3143418 [TBL] [Abstract][Full Text] [Related]
33. Modulation by cytosol and commercial proteins of acid-active phospholipase A2 from adrenal medulla. Bartolf M; Franson RC Biochim Biophys Acta; 1987 Feb; 917(2):308-17. PubMed ID: 3801505 [TBL] [Abstract][Full Text] [Related]
34. Induction of secretory phospholipase A2 confirms the systemic inflammatory nature of adjuvant arthritis. Lin MK; Katz A; van den Bosch H; Kennedy B; Stefanski E; Vadas P; Pruzanski W Inflammation; 1998 Apr; 22(2):161-73. PubMed ID: 9561926 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of substrate-mimicking cytosolic phospholipase A2 inhibitors--reducing the lipophilicity of the arachidonyl chain isostere. Walters I; Bennion C; Connolly S; Croshaw PJ; Hardy K; Hartopp P; Jackson CG; King SJ; Lawrence L; Mete A; Murray D; Robinson DH; Stein L; Wells E; John Withnall W Bioorg Med Chem Lett; 2004 Jul; 14(14):3645-9. PubMed ID: 15203135 [TBL] [Abstract][Full Text] [Related]
36. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. Burke JR; Davern LB; Stanley PL; Gregor KR; Banville J; Remillard R; Russell JW; Brassil PJ; Witmer MR; Johnson G; Tredup JA; Tramposch KM J Pharmacol Exp Ther; 2001 Jul; 298(1):376-85. PubMed ID: 11408565 [TBL] [Abstract][Full Text] [Related]
37. Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2. Murakami M; Kudo I; Nakamura H; Yokoyama Y; Mori H; Inoue K FEBS Lett; 1990 Jul; 268(1):113-6. PubMed ID: 2384146 [TBL] [Abstract][Full Text] [Related]
39. Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Murakami M; Kudo I; Suwa Y; Inoue K Eur J Biochem; 1992 Oct; 209(1):257-65. PubMed ID: 1382985 [TBL] [Abstract][Full Text] [Related]
40. A downstream role for protein kinase Calpha in the cytosolic phospholipase A2-dependent protective signalling mediated by peroxynitrite in U937 cells. Guidarelli A; Cerioni L; Tommasini I; Brüne B; Cantoni O Biochem Pharmacol; 2005 Apr; 69(8):1275-86. PubMed ID: 15794949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]